Lung cancer is the most common malignant neoplasm and the main cause of human death. Despite persistant development in the dignostics and therapy process, 5-year survival is still unsatisfactory. It is caused mostly by detecting lung cancer in advanced stage and that is why there is no posibility for radical treatment resection. Diagnostic and therapeutical progress in molecular biology creates a chance to make overall survival longer. In this paper authors present molecular determinants of lung cancer including main functions of p53, Rb, p16. MYC, RAS proteins and consequences of mutations within the genes encoding them. There is also showed a role of growth factors, apoptosis, angiogenesis and telomerase in the oncogenic transformation. B...
Diabetes mellitus (DM) is one of the fastest deadlygrowing diseases around the world and prostate ca...
Molecularly targeted therapy with EGFR tyrosine kinase inhibitors has become an important enhancemen...
Rak płuca jest najczęściej występującym nowotworem złośliwym w Polsce. Spośród nowotworów złośliwych...
Lung cancer is the most common malignant neoplasm and the main cause of human death. Despite persist...
Within the last years a concept of personalized medicine including individual treatment selection ha...
Bladder cancer is the ninth most common malignancy and thirteenth leading cause of cancer related de...
Molecular studies based on the analysys of a alterations in single or in a few genes did not produce...
Lung cancer is the leading cause of cancer related death. The results of treatment of advanced lung ...
Introduction. Lung cancer is the main cause of death due to cancer in Poland. The most important fac...
Small-cell lung cancer is characterised by an aggressive course with high tendency for early dissemi...
Myeloid malignancies are heterogenous group of disorders with complex molecular background and patho...
Introduction: Individual’s risk of developing lung cancer depends not only on exposure to toba...
Due to its increasing incidence, stilth course and resistance to classic pharmacotherapy, renal cell...
BCR-ABL1-like acute lymphoblastic leukemia (ALL) is newly identified subtype of high-risk B-cell pro...
Personalised therapy is currently a promising method of treatment for cancer patients. The dynamic d...
Diabetes mellitus (DM) is one of the fastest deadlygrowing diseases around the world and prostate ca...
Molecularly targeted therapy with EGFR tyrosine kinase inhibitors has become an important enhancemen...
Rak płuca jest najczęściej występującym nowotworem złośliwym w Polsce. Spośród nowotworów złośliwych...
Lung cancer is the most common malignant neoplasm and the main cause of human death. Despite persist...
Within the last years a concept of personalized medicine including individual treatment selection ha...
Bladder cancer is the ninth most common malignancy and thirteenth leading cause of cancer related de...
Molecular studies based on the analysys of a alterations in single or in a few genes did not produce...
Lung cancer is the leading cause of cancer related death. The results of treatment of advanced lung ...
Introduction. Lung cancer is the main cause of death due to cancer in Poland. The most important fac...
Small-cell lung cancer is characterised by an aggressive course with high tendency for early dissemi...
Myeloid malignancies are heterogenous group of disorders with complex molecular background and patho...
Introduction: Individual’s risk of developing lung cancer depends not only on exposure to toba...
Due to its increasing incidence, stilth course and resistance to classic pharmacotherapy, renal cell...
BCR-ABL1-like acute lymphoblastic leukemia (ALL) is newly identified subtype of high-risk B-cell pro...
Personalised therapy is currently a promising method of treatment for cancer patients. The dynamic d...
Diabetes mellitus (DM) is one of the fastest deadlygrowing diseases around the world and prostate ca...
Molecularly targeted therapy with EGFR tyrosine kinase inhibitors has become an important enhancemen...
Rak płuca jest najczęściej występującym nowotworem złośliwym w Polsce. Spośród nowotworów złośliwych...